Oxford Nanopore Technologies has teamed up with Cepheid to speed up infectious disease genomic analysis, blocking out recent noise of acquisition vulnerability. The UK biotech, a former star of the ...

Cepheid CPHD recently launched its Xpert MRSA NxG assay in the commercial markets overseas, after the test won the CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices.

SUNNYVALE, Calif., Sept. 29, 2020 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress ...

When the plot was written for Sunnyvale's Cepheid, it was a classic tale of turning swords into plowshares. Founded in 1996, the fledgling biotech company took fast new methods of DNA analysis ...

Shareholders ofCepheid(NASDAQ: CPHD), a molecular diagnostics company,are having a pleasant start to the short trading week. News broke this morning that the company has agreed to be acquired by ...

Molecular diagnostic test company Cepheid stock dropped 12% today after reporting earnings last night. Is the move justified, or just market noise? So what: Cepheid reported revenue of $132.5 million ...

Cepheid, a large biotechnology company known for single-use tests for various diseases like strep throat, is laying off 635 Bay Area employees. The company announced the dramatic cuts in WARN filings ...

SUNNYVALE, Calif., Aug. 13, 2015 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced the departure of Ilan Daskal who held the position of Executive Vice President, Chief Financial Officer. Mr.